课题基金 / 基金详情

ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS

ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
自身免疫性关节炎中 T 细胞激活的改变
批准号:
7393777
负责人:
JIAN ZHANG
金额:
$18.69万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2009-02-28

项目摘要

项目成果

JIAN ZHANG的其他基金

相似基金

相关文献

中文摘要
翻译
过度刺激的T细胞的激活诱导的细胞死亡(AICD)已被认为是稳态和预防自身免疫的重要机制。通过T细胞抗原受体(TCR)反复刺激T细胞,可诱导T细胞表面Fas和Fas配体(FasL)共表达,Fas与FasL相互作用导致T细胞“自杀”或“自相残杀”。蛋白多糖诱导的关节炎(Proteoglycan,PG)是一种新型的自身免疫性关节炎模型。在该模型中,外周血CD 4 + T细胞对TCR刺激的异常增殖反应被抑制。 与关节炎小鼠中低水平的AICD和高比例的干扰素(IFN)-γ与白细胞介素(IL)-4相关。PGIA小鼠的AICD缺陷和CD 4 + T细胞过度增殖可能归因于未能诱导细胞Fas相关死亡结构域(FADD)样IL-1 β转化酶(FLICE)抑制蛋白(c-FLIP)的降解。与野生型(Wt)BALB/c小鼠相比,IL-4缺陷(IL-4-/-)小鼠中PGIA的发生率和严重程度增加,而对BALB/c小鼠施用IL-4可大大降低疾病。此外,PG-致敏的IL-4-/-CD 4 + T细胞不能经历凋亡。基于这些观察结果,我们假设IL-4的缺失导致诱导c-FLIP降解的失败,这反过来又导致AICD缺陷和外周中自身反应性Th 1型细胞的过度增殖,从而导致PGIA的发展。为了证实我们的假设,我们提出三个 具体目标:(1)我们将确定IL-4缺失是否以及如何导致PGIA小鼠体内CD 4 + T细胞的积聚:(2)我们将研究c-FLIP是否调节PGIA小鼠中致关节炎性CD 4 + T细胞的过度增殖和缺陷AICD;(3)确定IL-4是否通过调节细胞周期进程来调节自身反应性T细胞对AICD的易感性,并研究IL-4是否通过控制c-FLIP表达来调节细胞周期进程。拟议的研究所产生的信息将增强我们对IL-4的生物学功能的理解,并将为自身免疫性关节炎的新治疗方法的发展提供启示。
英文摘要
Activation-induced cell death (AICD) of over-stimulated T cells has been proposed to be an important mechanism in homeostasis and the prevention of autoimmunity. Repeated stimulation of T cells through T cell antigen receptor (TCR) induces co-expression of Fas and Fas ligand (FasL) on the surface of T cells, and the Fas-FasL interaction leads to the "suicide" or "fratricide" of T cells. Proteoglycan (PG)-induced arthritis (PGIA) is a novel autoimmune murine model induced by systemic immunization of mice with cartilage PG. In this model, an aberrant proliferation of peripheral CD4+ T cells in vitro in response to TCR stimulation was associated with low levels of AICD and a high ratio of interferon (IFN)-gamma to interleukin (IL)-4 in arthritic mice. The defective AICD and hyper-proliferation of CD4+ T cells in mice with PGIA may be ascribed to failure of inducing degradation of cellular Fas-associated death domain (FADD)-like IL-1beta-converting enzyme (FLICE)-inhibitory protein (c-FLIP). The incidence and severity of PGIA is augmented in IL-4-deficient (IL-4-/-) mice in comparison to wild-type (Wt) BALB/c mice, whereas administration of IL-4 to BALB/c mice greatly reduces disease. Moreover, PG-primed IL-4-/- CD4 + T cells fail to undergo apoptosis. Based upon these observations, we hypothesize that loss of IL-4 leads to a failure of inducing c-FLIP degradation which in turn results in defective AICD and hyperproliferation of autoreactive Th1-type cells in the periphery, thus leading to the development of PGIA. To confirm our hypothesis, we propose three specific aims: (1) We will define whether and how loss of IL-4 results in accumulation of CD4+ T cells in IL-4-/- mice with PGIA in vivo; (2) We will investigate whether c-FLIP regulates hyper-proliferation and defective AICD of arthritogenic CD4+ T cells in IL-4-/- mice with PGIA; and (3) We will determine whether IL-4 regulates the susceptibility of autoreactive T cells to AICD by adjusting cell cycle progression, and investigate whether IL-4 regulates cell cycle progression through controlling c-FLIP expression. The information generated by the proposed studies will enhance our understanding of the biological function of IL-4 and will shed light on the development of novel therapeutic approaches to autoimmune arthritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Protein Ubiquitination in Sepsis
  • 批准号:
    9551775
  • 项目类别:
  • 资助金额:
    $28.74万
  • 财政年份:
    2017
  • 负责人:
    JIAN ZHANG
  • 依托单位:
NEDD4 IN T HELPER CELL DEVELOPMENT AND AUTOIMMUNITY
  • 批准号:
    9547050
  • 项目类别:
  • 资助金额:
    $51.41万
  • 财政年份:
    2017
  • 负责人:
    JIAN ZHANG
  • 依托单位:
Regulation of Innate Immune System Sensing of C. albicans Infection
  • 批准号:
    9262609
  • 项目类别:
  • 资助金额:
    $1.32万
  • 财政年份:
    2016
  • 负责人:
    JIAN ZHANG
  • 依托单位:
Role of Protein Ubiquitination in Sepsis
  • 批准号:
    9303271
  • 项目类别:
  • 资助金额:
    $5.27万
  • 财政年份:
    2016
  • 负责人:
    JIAN ZHANG
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究